Health Canada drug identification number

DIN 02524627 — SOHONOS 1 MG

SOHONOS is a capsule of Palovarotene marketed by IPSEN BIOPHARMACEUTICALS CANADA INC. The full Palovarotene monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02524627
Brand name
SOHONOS
Active ingredient
Palovarotene
Strength
1 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
IPSEN BIOPHARMACEUTICALS CANADA INC
Health Canada status
MARKETED
Drug class
Retinoid / retinoic acid receptor gamma (RARγ) selective agonist

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Palovarotene products

DINBrandStrengthFormManufacturerStatus
02524635 SOHONOS 1.5 MG CAPSULE IPSEN BIOPHARMACEUTICALS CANADA INC MARKETED
02524678 SOHONOS 10 MG CAPSULE IPSEN BIOPHARMACEUTICALS CANADA INC MARKETED
02524643 SOHONOS 2.5 MG CAPSULE IPSEN BIOPHARMACEUTICALS CANADA INC MARKETED
02524651 SOHONOS 5 MG CAPSULE IPSEN BIOPHARMACEUTICALS CANADA INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.